EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Enhanced Antitumor Immunity Through T Cell Activation with Optimized Tandem Double-OX40L mRNAs

Zhuoya Deng, Yuying Tian, Jing Wang, Yongru Xu, Zherui Liu, Zhaohui Xiao, Zhaohai Wang, Minggen Hu, Rong Liu iD, Penghui Yang

International Journal of Nanomedicine · 2025

DOI: 10.2147/ijn.s479434 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Zhuoya Deng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Hepato-Pancreato-Biliary Surgery, Institute of Hepatobiliary Surgery, the First Medical Center, Chinese PLA General Hospital, Beijing, Peo…. Hauptthemen laut MEDLINE: RNA, Messenger, OX40 Ligand, Antineoplastic Agents, T-Lymphocytes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, MessengerOX40 LigandAntineoplastic AgentsT-LymphocytesAnimalsMiceTumor MicroenvironmentCell Line, TumorLymphocyte ActivationNanoparticlesHumansFemaleCD8-Positive T-LymphocytesMice, Inbred C57BLCD4-Positive T-LymphocytesLipidsLiposomes

Stichwörter der Autor:innen

OX40L mRNAlipid nanoparticlesmalignant tumortumor immune microenvironmenttumor immunotherapy

Substanzen

RNA, MessengerOX40 LigandLipid NanoparticlesAntineoplastic AgentsLipidsLiposomes

Autor:innen und Institutionen

  • Faculty of Hepato-Pancreato-Biliary Surgery, Institute of Hepatobiliary Surgery, the First Medical Center, Chinese PLA General Hospital, Beijing, People's Republic of China.
  • Beijing Youan Hospital, Capital Medical University, Beijing, People's Republic of China.
  • The Fifth Medical Center, Chinese PLA General Hospital, Beijing, People's Republic of China.
  • Peking University 302 Clinical Medical School, Peking University, Beijing, People's Republic of China.

ORCID-Profile: Rong Liu

Zitieren

APA

Deng, Z., Tian, Y., Wang, J., Xu, Y., Liu, Z., Xiao, Z., Wang, Z., Hu, M., Liu, R., & Yang, P. (2025). Enhanced Antitumor Immunity Through T Cell Activation with Optimized Tandem Double-OX40L mRNAs. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s479434

Vancouver

Deng Z, Tian Y, Wang J, Xu Y, Liu Z, Xiao Z, et al. Enhanced Antitumor Immunity Through T Cell Activation with Optimized Tandem Double-OX40L mRNAs. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s479434

BibTeX
@article{Deng2025,
  author = {Deng, Zhuoya and Tian, Yuying and Wang, Jing and Xu, Yongru and Liu, Zherui and Xiao, Zhaohui and Wang, Zhaohai and Hu, Minggen and Liu, Rong and Yang, Penghui},
  title = {Enhanced Antitumor Immunity Through T Cell Activation with Optimized Tandem Double-OX40L mRNAs},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  doi = {10.2147/ijn.s479434}
}
Kostenlos starten →